Potent corticosteroid + keratolytic
Betamethasone with salicylic acid
Brand names: Diprosalic
Adult dose
Dose: Apply BD to affected area
Route: Topical
Frequency: BD
Clinical pearls
- BAD: thick hyperkeratotic plaque psoriasis where TC + salicylic acid combined
- NICE CG153 psoriasis
Contraindications
- Children
- Severe peripheral vascular disease
- Open wounds
- Salicylate sensitivity
- Hypersensitivity
Side effects
- Skin atrophy
- Salicylate toxicity (extensive use)
- Local irritation
- Folliculitis
Interactions
- Anticoagulants (extensive use)
Monitoring
- Skin response
- Local atrophy
- Salicylate effect (large area)
Reference: BNF; NICE CG153; BAD; https://bnf.nice.org.uk/drugs/betamethasone-with-salicylic-acid/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD